FOCUS study melanoma

• New Approvals
• New Drug Applications

FDA Approves HEPZATO KIT for Uveal Melanoma with Unresectable Hepatic Metastases

By Dr. Anish Shah Bronx-Lebanon Hospital   On August 14, 2023, the U.S. Food and Drug Administration approved HEPZATO KIT…